Larimar Therapeutics Reports Second Quarter 2020 Operating and Financial Results
Go back to Larimar Therapeutics Reports Second Quarter 2020 Operating and Financial Results| (NASDAQ: LRMR) | Delayed: 3.25 +0.05 (1.56%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.20 | 52 Week High | $ | |||
| Open | $3.23 | 52 Week Low | $ | |||
| Day High | $3.35 | P/E | N/A | |||
| Day Low | $3.15 | EPS | $ | |||
| Volume | 1,278,874 | |||||

